Originally Aired: July 7, 2021
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Biomedical researchers within pharma, biotech, and academic settings spend approximately $1 billion over ten years to develop a new drug. Optimizing each step of the drug discovery pipeline from target ID to the clinic is critical to success—otherwise, setbacks may result, such as costly delays, or in the worst-case scenario, late-stage attrition.
Anticipating these potential challenges, solutions are continually being developed to keep the process moving forward while minimizing risk. These include orthologous methods for interrogating mechanisms of action, identifying and validating biomarkers, and characterizing drivers of sensitivity and resistance. As a CRO, Horizon Discovery applies its CRISPR gene editing and modulation expertise, as well as its complementary cell-based services to provide support to the scientific community.
In this GEN webinar, Dr. Cathrine Ulich will discuss options to guide you through the drug development process and outline ways to improve the success of your research goals. Additionally, she will provide examples of alternative strategies that can be employed to address common issues along the drug discovery and validation pipeline to enable forward progression.
A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelist.
Produced with support from: